JPMorgan Chase & Co. Boosts Stock Holdings in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

JPMorgan Chase & Co. lifted its position in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 36.2% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,443 shares of the company’s stock after buying an additional 1,182 shares during the period. JPMorgan Chase & Co. owned approximately 0.09% of SPDR S&P Pharmaceuticals ETF worth $197,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in XPH. BNP Paribas Financial Markets lifted its stake in shares of SPDR S&P Pharmaceuticals ETF by 208.6% in the 3rd quarter. BNP Paribas Financial Markets now owns 149,419 shares of the company’s stock valued at $6,628,000 after purchasing an additional 101,000 shares in the last quarter. First Citizens Bank & Trust Co. boosted its position in SPDR S&P Pharmaceuticals ETF by 9.5% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 72,053 shares of the company’s stock worth $3,196,000 after purchasing an additional 6,227 shares during the period. Stifel Financial Corp acquired a new stake in SPDR S&P Pharmaceuticals ETF in the 3rd quarter valued at $337,000. Finally, AlphaMark Advisors LLC raised its position in SPDR S&P Pharmaceuticals ETF by 5.9% in the third quarter. AlphaMark Advisors LLC now owns 6,225 shares of the company’s stock valued at $276,000 after purchasing an additional 348 shares during the period.

SPDR S&P Pharmaceuticals ETF Price Performance

Shares of NYSEARCA XPH opened at $45.06 on Friday. SPDR S&P Pharmaceuticals ETF has a 1-year low of $38.88 and a 1-year high of $48.76. The company has a market capitalization of $218.54 million, a price-to-earnings ratio of 14.39 and a beta of 0.87. The business has a 50-day moving average of $44.40 and a 200-day moving average of $44.37.

SPDR S&P Pharmaceuticals ETF Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.